Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGOBSERVATIONAL

Chronic Intestinal Pathologies Analytical Cohort at TouLouse

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

In the general population, the percentage of people with at least one digestive disease is 16.7%. Among these digestive diseases, inflammatory bowel disease (IBD), irritable bowel syndrome (IBS) and patients who should benefit from digestive examinations as part of a screening oriented either by the patient's family history or following the performance of an immunological screening test ( FIT) in the stool will be studied. The aim of this project is to build a biological collection with associated clinical data for research projects.

Who May Be Eligible (Plain English)

Who May Qualify: - Patient requiring endoscopic explorations for screening or follow-up in the context of a suspected IBS or IBD or colorectal cancer Or - Patient with IBD requiring surgical management - Patient over 18 years old - Patient able to read and understand the information leaflet - Patients who have given their consent to participate in the study - Patients affiliated to a social security system (including AME) Who Should NOT Join This Trial: - Patients who have received antibiotic treatments in the 10 days preceding endoscopic exploration - Pregnant or breastfeeding patients - Patients under 18 years old - Patients under guardianship or curatorship - Patients unable to sign a free and willing to sign a consent form Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Patient requiring endoscopic explorations for screening or follow-up in the context of a suspected IBS or IBD or colorectal cancer Or * Patient with IBD requiring surgical management * Patient over 18 years old * Patient able to read and understand the information leaflet * Patients who have given their consent to participate in the study * Patients affiliated to a social security system (including AME) Exclusion Criteria: * Patients who have received antibiotic treatments in the 10 days preceding endoscopic exploration * Pregnant or breastfeeding patients * Patients under 18 years old * Patients under guardianship or curatorship * Patients unable to sign a free and informed consent

Treatments Being Tested

BIOLOGICAL

blood and intestinal biopsy sampling

24 mL of blood and 10 intestinal biopsies will be sampled

Locations (1)

Rangueil University Hospital
Toulouse, France